The colorectal cancer immune microenvironment and approach to immunotherapies.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Future Oncology

• Publication date

  2017-08-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/fon-2017-0145PMID 28829193PMCID PMC6817965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.

  2017cited by this paper
• Regulation of hypoxia‐inducible gene expression after HIF activation

  2017cited by this paper
• Colorectal cancer statistics, 2017

  2017cited by this paper
• Microsatellite Instability Pathway and EMAST in Colorectal Cancer

  2017cited by this paper
• The mortality reducing effect of aspirin in colorectal cancer patients: Interpreting the evidence.

  2017cited by this paper
• Microbiota: a key orchestrator of cancer therapy

  2017cited by this paper
• Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study

  2017cited by this paper
• Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

  2016cited by this paper
• Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells

  2016cited by this paper
• Sa1787 Loss of Heterozygosity (LOH) at the Hypoxia Inducible Factor 3A (HIF3A) Locus and Loss of Protein Expression is Acquired in Colorectal Cancer (CRC) Metastasis

  2016cited by this paper
• Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.

  2016cited by this paper
• Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

  2016cited by this paper
• Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.

  2016cited by this paper
• Gut Microbiota, Inflammation, and Colorectal Cancer.

  2016cited by this paper
• The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis

  2016cited by this paper
• Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.

  2016cited by this paper
• Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.

  2016cited by this paper
• Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.

  2016cited by this paper
• Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy

  2016cited by this paper
• Advances in targeted and immunobased therapies for colorectal cancer in the genomic era

  2016cited by this paper
• Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy

  2015cited by this paper
• Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer

  2015cited by this paper
• Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer

  2015cited by this paper
• Safety and efficacy of MPDL3280A (anti-PDL1) in combination with bevacizumab (bev) and/or FOLFOX in patients (pts) with metastatic colorectal cancer (mCRC).

  2015cited by this paper
• Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.

  2015cited by this paper
• The Consensus Molecular Subtypes of Colorectal Cancer

  2015cited by this paper
• Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cells.

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology

  2015cited by this paper
• Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer

  2015cited by this paper
• Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

  2015cited by this paper
• Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer

  2015cited by this paper
• EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression

  2015cited by this paper
• Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.

  2015cited by this paper
• Stromal gene expression defines poor-prognosis subtypes in colorectal cancer

  2015cited by this paper
• A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts

  2015cited by this paper
• PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

  2015cited by this paper
• Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

  2015cited by this paper
• T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes

  2015cited by this paper
• Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer

  2015cited by this paper
• Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.

  2015cited by this paper
• Fusobacterium in colonic flora and molecular features of colorectal carcinoma.

  2014cited by this paper
• Microbiota organization is a distinct feature of proximal colorectal cancers

  2014cited by this paper
• Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

  2013cited by this paper
• Proteome Profiling of Cancer-Associated Fibroblasts Identifies Novel Proinflammatory Signatures and Prognostic Markers for Colorectal Cancer

  2013cited by this paper
• COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA

  2013cited by this paper
• Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

  2013cited by this paper
• Nivolumab plus ipilimumab in advanced melanoma.

  2013cited by this paper
• Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance.

  2013cited by this paper
• Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

  2012cited by this paper
• MSH3-Deficiency Initiates EMAST without Oncogenic Transformation of Human Colon Epithelial Cells

  2012cited by this paper
• Cancer classification using the Immunoscore: a worldwide task force

  2012cited by this paper
• Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms

  2012cited by this paper
• Association between recurrent metastasis from stage II and III primary colorectal tumors and moderate microsatellite instability.

  2012cited by this paper
• Cancer-associated fibroblasts as targets for immunotherapy.

  2012cited by this paper
• The roles of mast cells in anticancer immunity

  2012cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

  2012cited by this paper
• Oxidative Stress Induces Nuclear-to-Cytosol Shift of hMSH3, a Potential Mechanism for EMAST in Colorectal Cancer Cells

  2012cited by this paper
• Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.

  2011cited by this paper
• Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

  2011cited by this paper
• Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer

  2011cited by this paper
• Microsatellite Instability, EMAST, and Morphology Associations with T Cell Infiltration in Colorectal Neoplasia

  2011cited by this paper
• The PD‐1 pathway in tolerance and autoimmunity

  2010cited by this paper
• Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer.

  2010cited by this paper
• 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.

  2010cited by this paper
• Relationship of EMAST and Microsatellite Instability Among Patients with Rectal Cancer

  2010cited by this paper
• Immune evasion of microsatellite unstable colorectal cancers

  2010cited by this paper
• Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.

  2010cited by this paper
• Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias.

  2010cited by this paper
• Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer.

  2010cited by this paper
• Immunogenic death of colon cancer cells treated with oxaliplatin

  2010cited by this paper
• Fusobacterium nucleatum Outer Membrane Proteins Fap2 and RadD Induce Cell Death in Human Lymphocytes

  2010cited by this paper
• Natural killer cells and cancer: Regulation by the killer cell Ig-like receptors (KIR)

  2009cited by this paper
• Coordination of intratumoral immune reaction and human colorectal cancer recurrence.

  2009cited by this paper
• Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype

  2009cited by this paper
• Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan.

  2009cited by this paper
• In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

  2009cited by this paper
• Genomic and epigenetic instability in colorectal cancer pathogenesis.

  2008cited by this paper
• Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer.

  2008cited by this paper
• Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.

  2008cited by this paper
• Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.

  2008cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers.

  2005cited by this paper
• Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth

  2005cited by this paper
• Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.

  2005cited by this paper
• Effector memory T cells, early metastasis, and survival in colorectal cancer.

  2005cited by this paper
• Systematic review of microsatellite instability and colorectal cancer prognosis.

  2005cited by this paper
• A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

  2003cited by this paper
• Cytotoxic T lymphocytes: all roads lead to death

  2002cited by this paper
• Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.

  1999cited by this paper
• Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.

  1999cited by this paper
• A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

  1998cited by this paper
• CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

  1998cited by this paper
• T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

  1998cited by this paper
• Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.

  1996cited by this paper
• Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation.

  1994cited by this paper
• Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.

  1994cited by this paper
• Characterization of activated lymphocytes in colon cancer.

  1989cited by this paper
• Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

  1987cited by this paper

• The Clinical Significance of the Inflammatory Response Index in Clear Cell Renal Cell Carcinoma and Its Application Progress in Immunotherapy

  2026cites this paper
• Comprehensive analysis reveals the molecular heterogeneity and the differences in prognosis and immunotherapy sensitivity in hypermutated colorectal cancer

  2026cites this paper
• Understanding the Tumor Microenvironmental Mechanisms Driving Immunotherapy Resistance in Colorectal Cancer Liver Metastases

  2025influential citation
• Prevalence of germline MSH3 polymorphisms in ulcerative colitis and early-onset colorectal cancer patients that potentiates inflammation-to-cancer transformation.

  2025cites this paper
• Immunomodulatory Intraperitoneal Chemotherapy with DACHPt-Loaded Biomaterial Nanoparticles in Colorectal Carcinomatosis.

  2025cites this paper
• Immunological landscape of colorectal cancer: tumor microenvironment, cellular players and immunotherapeutic opportunities

  2025cites this paper
• Development and validation of a novel risk stratification signature derived from migrasome and tumor microenvironment-related genes for molecular subtyping and improving clinical outcomes in head and neck squamous cell carcinoma

  2025cites this paper
• Machine learning-driven immune signature identification for enhanced prognostic stratification and personalized therapy in colorectal Cancer: An AI-powered multi-omics approach

  2025cites this paper
• Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on endoplasmic reticulum stress-related and immune-related genes

  2025cites this paper
• The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancer

  2025cites this paper
• Research progress on the mechanism and treatment of cachexia based on tumor microenvironment.

  2025cites this paper
• Adoptive immune cell therapy for colorectal cancer

  2025cites this paper
• TTI1 indicates a poor prognosis and is associated with metastasis and immunosuppression of colorectal cancer

  2025cites this paper
• Colorectal Cancers and Microsatellite Instability

  2025cites this paper
• A dynamic molecular landscape in colorectal cancer progression at single-cell resolution

  2025cites this paper
• Molecular Subtypes, microRNAs and Immunotherapy Response in Metastatic Colorectal Cancer

  2024influential citation
• Compound heterozygous MSH3 germline variants and associated tumor somatic DNA mismatch repair dysfunction

  2024cites this paper
• Unraveling molecular and clinical aspects of ALKBH5 as dual role in colorectal cancer.

  2024cites this paper
• Effects of postoperative treatment with chemotherapy and cellular immunotherapy on patients with colorectal cancer

  2024cites this paper
• In-Depth Proteomic Analysis of Paraffin-Embedded Tissue Samples from Colorectal Cancer Patients Revealed TXNDC17 and SLC8A1 as Key Proteins Associated with the Disease.

  2024cites this paper
• Target therapy of TIGIT; a novel approach of immunotherapy for the treatment of colorectal cancer

  2024cites this paper
• Deciphering the Role of EPPK1 in the Development of Colon Adenocarcinoma by Integrated Bioinformatics Approach

  2024cites this paper
• Effect of colorectal cancer stem cells on the development and metastasis of colorectal cancer

  2024cites this paper
• Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy

  2024cites this paper
• THE JEREMIAH METZGER LECTURE: ENVIRONMENTAL INFLUENCES ON COLORECTAL CANCER.

  2024cites this paper
• Mindfulness intervention, homogeneous medical concept, and concentrated solution nursing for colorectal cancer patients: a retrospective study

  2024cites this paper
• LINC00339 accelerates invasion and migration of colorectal cancer via mediating miRNA-30a-5p.

  2023cites this paper
• Exploration and validation of the Ki67, Her-2, and mutant P53 protein-based risk model, nomogram and lymph node metastasis model for predicting colorectal cancer progression and prognosis

  2023cites this paper
• Construction of a TTN Mutation-Based Prognostic Model for Evaluating Immune Microenvironment, Cancer Stemness, and Outcomes of Colorectal Cancer Patients

  2023cites this paper
• Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal Cancer

  2023cites this paper
• Association of clinical outcomes and the predictive value of T lymphocyte subsets within colorectal cancer patients

  2023cites this paper
• ALKBH5 Drives Immune Suppression via targeting AXIN2 to Promote Colorectal Cancer and is a Target for Boosting Immunotherapy.

  2023cites this paper
• The Role of RNA Methylation Modification Related Genes in Prognosis and Immunotherapy of Colorectal Cancer

  2023cites this paper
• Exploring the immune microenvironment in small bowel adenocarcinoma using digital image analysis

  2023cites this paper
• Membrane Trafficking-Related Genes Predict Tumor Immune Microenvironment and Prognosis in Colorectal Cancer

  2023cites this paper
• Fusobacterium nucleatum Load Correlates with KRAS Mutation and Sessile Serrated Pathogenesis in Colorectal Adenocarcinoma

  2023cites this paper
• Dendritic cell-targeting chemokines inhibit colorectal cancer progression

  2022cites this paper
• System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer

  2022cites this paper
• Classification of colorectal cancer into clinically relevant subtypes based on genes and mesenchymal cells

  2022cites this paper
• Novel six-gene prognostic signature based on colon adenocarcinoma immune-related genes

  2022cites this paper
• Colorectal Cancer and Purinergic Signalling: An Overview

  2022cites this paper
• Metabolic pathways regulating colorectal cancer: a potential therapeutic approach.

  2022cites this paper
• Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer

  2022cites this paper
• Cancer Stem Cells in Tumor Microenvironment of Adenocarcinoma of the Stomach, Colon, and Rectum

  2022cites this paper
• Commencing colorectal cancer screening at age 45 years in U.S. racial groups

  2022cites this paper
• Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma

  2022cites this paper
• Polo-like kinase 4 is associated with advanced TNM stages and reduced survival and its inhibition improves chemosensitivity in colorectal cancer

  2022cites this paper
• Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer

  2022cites this paper
• Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives

  2022cites this paper
• Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment

  2022cites this paper
• A Prognostic Model of Colon Cancer Based on the Microenvironment Component Score via Single Cell Sequencing

  2022cites this paper
• Comprehensive Analysis of Colorectal Cancer Immunity and Identification of Immune-Related Prognostic Targets

  2022cites this paper
• Evaluation of Galanin Expression in Colorectal Cancer: An Immunohistochemical and Transcriptomic Study

  2022cites this paper
• Immune cell infiltration-associated signature in colon cancer and its prognostic implications

  2021cites this paper
• Comprehensive Analysis of Immune Related Genes in the Tumor Microenvironment of Colorectal Cancer

  2021cites this paper
• The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia

  2021influential citation
• Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer

  2021cites this paper
• Aloperine Inhibits Proliferation and Promotes Apoptosis in Colorectal Cancer Cells by Regulating the circNSUN2/miR-296-5p/STAT3 Pathway

  2021cites this paper
• Actinidia eriantha Polysaccharide and PD1-Antibody Combination Therapy Enhances Antitumor Efficacy in Colorectal Cancer–Xenograft Mice

  2021cites this paper
• T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer

  2021cites this paper
• Colorectal Cancer and Immunity: From the Wet Lab to Individuals

  2021influential citation
• CD163+ macrophages suppress T cell response by producing TGF-β in pediatric colorectal polyps.

  2021cites this paper
• Molecular correlates of immune cytolytic subgroups in colorectal cancer by integrated genomics analysis

  2021cites this paper
• An immune-related model based on INHBA, JAG2 and CCL19 to predict the prognoses of colon cancer patients

  2021cites this paper
• Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer

  2021cites this paper
• A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers

  2021cites this paper
• Racial and ethnic disparities in colorectal cancer incidence and mortality.

  2021cites this paper
• N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients

  2021cites this paper
• Colorectal Cancer, Liver Metastases and Biotherapies

  2021cites this paper
• INHBA is a novel mediator regulating cellular senescence and immune evasion in colorectal cancer

  2021cites this paper
• Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects

  2021cites this paper
• Intratumoral and peritumoral lymphocytic responses correlate with survival in rectal cancer

  2021cites this paper
• The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer

  2021cites this paper
• SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer

  2021cites this paper
• Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma

  2021cites this paper
• Clinical Signi cance of COL11A1 and Its Effect on Immune In ltration in Colorectal Cancer

  2021cites this paper
• OTT_A_294253 1239..1248

  2021cites this paper
• DDDT_A_288473 857..870

  2021cites this paper
• Identi ed and Validated the Characterization of the Colorectal Cancer Tumor Immune Microenvironment

  2020cites this paper
• Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis

  2020cites this paper
• Rapid screening for individualized chemotherapy optimization of colorectal cancer: A novel conditional reprogramming technology-based functional diagnostic assay.

  2020cites this paper
• Mining the potential prognostic value of synaptosomal-associated protein 25 (SNAP25) in colon cancer based on stromal-immune score

  2020cites this paper
• PD-1 blockade as a future treatment for colorectal cancer with microsatellite instability

  2020cites this paper
• Overcoming resistance to immunotherapy through multimodal approaches: is there hope for colorectal cancer?

  2020cites this paper
• Immunological Features with DNA Microsatellite Alterations in Patients with Colorectal Cancer.

  2020cites this paper
• Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms

  2020cites this paper
• A novel prognostic signature of immune‐related genes for patients with colorectal cancer

  2020cites this paper
• Assaying Circulating-Tumor DNA To Predict Recurrence of Localized Colon Cancer.

  2020cites this paper
• High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer

  2020cites this paper
• Carcinoma and Sarcoma Microenvironment at a Glance: Where We Are

  2020cites this paper
• Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies.

  2020cites this paper
• Exosomal miRNA: Small Molecules, Big Impact in Colorectal Cancer

  2019cites this paper
• High predictability for identifying Lynch syndrome via microsatellite instability testing or immunohistochemistry in all Lynch-associated tumor types.

  2019cites this paper
• Prognostic factors in colorectal cancer : studies of thymidylate synthase expression, mismatch repair protein expression, tumor budding and t-cell infiltration

  2019cites this paper
• LncRNA, a novel target biomolecule, is involved in the progression of colorectal cancer.

  2019cites this paper
• Clinical significance of MLH1/MSH2 for stage II/III sporadic colorectal cancer

  2019cites this paper
• Exogenous interleukin‐1&agr; signaling negatively impacts acquired chemoresistance and alters cell adhesion molecule expression pattern in colorectal carcinoma cells HCT116

  2019cites this paper
• The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer

  2019cites this paper
• Fusobacterium nucleatum Infection in Colorectal Cancer: Linking Inflammation, DNA Mismatch Repair and Genetic and Epigenetic Alterations

  2018cites this paper
• Targeting Interleukin-6 (IL-6) Sensitizes Anti-PD-L1 Treatment in a Colorectal Cancer Preclinical Model

  2018cites this paper